| Serial Number | 77942356 |
| Word Mark | YUROXAN |
| Filing Date | Tuesday, February 23, 2010 |
| Status | 710 - CANCELLED - SECTION 8 |
| Status Date | Friday, May 25, 2018 |
| Registration Number | 4040189 |
| Registration Date | Tuesday, October 18, 2011 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, August 2, 2011 |
| Goods and Services | Pharmaceutical and veterinary preparations for humans and animals, namely, medicines, vaccines, and serums for diagnostics, testing, prevention, treatment, and therapeutics, in particular medicines for treating cardiovascular illnesses, in particular hyperlipidaemia, coronary heart diseases and cardiac insufficiency; medicines for the treatment of immunological diseases, in particular autoimmune diseases in particular rheumatic disorders, polychondritis, Bechterew's disease, fibromyalgia and lupus erythematodes, rheumatoid arthritis, polyarthritis, Crohn's disease, and multiple sclerosis; medicines for treating skin diseases, in particular acne, actinic keratosis, alopecia, atopic dermatitis, Bowen's disease, cutaneous atopy, cutaneous T-cell lymphoma, Darrier's disease, Dartroud diathesis, dermatitis, eczema, genital herpes, genital warts, herpes, hyperkeratosis, hyperpigmentation, hyperplasia of the epidermis, hypopigmentation, ichthyosis, increased proliferation of skin cells, keloids, lentigo, lichen planus, melasma, molluscum contagiosum, mycosis fungoides, neoplasias, neurodermitis, pigmentation disorders, porokeratosis of Mibelli, psoriasis, removal of tattoos, rosacea, seborrhea, seborrheic keratosis, shingles, skin diseases related to inflammatory processes of skin cells, skin ulcers, vitiligo, warts, xerosis; medicines for treating tumourous diseases, in particular Astrocytomas, basal cell carcinomas, biliary cancers, bladder cancers, bone cancers, brain cancers, breast cancers, carcinomas, cervical cancers, cervical intraepithelial neoplasias, colorectal cancers, endocrine system cancers, ependymomas, epidermoid carcinomas, fibrosarcomas, gastric cancers, gastrointestinal cancers, glioblastomas, gynecologic cancers, head and neck cancers, hemangiomas, hepatomas, Hodgkin's lymphomas, Leukemia, liver cancers, lung cancers, lymphomas, medulloblastomas, meningiomas, mesothelaiomas, metastases, myelomas, neoplasias, neurectodermal cancers, neuroblastomas, neurofibromas, neurofibrosarcomas, neuronal cancers, non-Hodgkin's lymphomas, oligodendrogliomas, ovarian carcinoma, pancreatic cancers, pediatric cancers, penile cancer, pituitary adenomas, pleural cancers, renal cancer, sarcomas, Schwannomas, skin cancers, sqamous cell carcinomas, testicular cancers, thyroid cancers, thyroid tumors, urinary tract cancers, carcinoma of the prostate, melanoma, Kaposi's sarcoma, hepatocellular carcinoma; ALL OF THE ABOVE CONSISTING OF low-molecular active substances, liposomes, aptamers, nucleic acids, peptides, proteins, protein conjugates, antibodies, T-cell proteins, enzymes and enzyme preparations, hormones, hormone analogues, attenuated viruses, virus-type particles and plant extracts |
| Translation of Words in Mark | The wording "YUROXAN" has no meaning in a foreign language. |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, May 25, 2018 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | MediGene AG |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | Planegg/Martinsried DE |
| Party Name | MediGene AG |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Planegg/Martinsried DE |
| Party Name | MediGene AG |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Planegg/Martinsried DE |
| Event Date | Event Description |
| Friday, May 25, 2018 | CANCELLED SEC. 8 (6-YR) |
| Tuesday, October 18, 2016 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| Tuesday, October 18, 2011 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, August 2, 2011 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, August 2, 2011 | PUBLISHED FOR OPPOSITION |
| Tuesday, June 28, 2011 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Friday, June 24, 2011 | ASSIGNED TO LIE |
| Wednesday, June 22, 2011 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, June 22, 2011 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, June 22, 2011 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, June 22, 2011 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, June 22, 2011 | EXAMINERS AMENDMENT -WRITTEN |
| Monday, January 3, 2011 | NOTIFICATION OF PRIORITY ACTION E-MAILED |
| Monday, January 3, 2011 | PRIORITY ACTION E-MAILED |
| Monday, January 3, 2011 | PRIORITY ACTION WRITTEN |
| Monday, November 29, 2010 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, November 29, 2010 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, November 29, 2010 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Saturday, May 29, 2010 | NOTIFICATION OF PRIORITY ACTION E-MAILED |
| Saturday, May 29, 2010 | PRIORITY ACTION E-MAILED |
| Saturday, May 29, 2010 | PRIORITY ACTION WRITTEN |
| Thursday, May 27, 2010 | ASSIGNED TO EXAMINER |
| Monday, March 1, 2010 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Friday, February 26, 2010 | NEW APPLICATION ENTERED IN TRAM |